ULTRAMAR.BO Earnings Beat: Q2 2026 Results Recap

Ultramarine & Pigments Limited released its ULTRAMAR.BO (Ultramarine & Pigments Limited) Q2 2026 earnings on (May 20, 2026), delivering solid financial performance despite market headwinds. The specialty chemicals company reported $1.96 billion in revenue and $6.63 earnings per share, reflecting strong operational execution in its core segments. However, ULTRAMAR.BO stock declined 3.15% following the announcement, closing at $405.40, signaling investor caution despite the solid results.

ULTRAMAR.BO Earnings Preview: EPS and Revenue Expectations

The company delivered $1.96 billion in quarterly revenue, demonstrating resilience in the specialty chemicals sector. Earnings per share reached $6.63, reflecting improved profitability compared to trailing twelve-month EPS of $28.63. This quarter’s performance shows consistent execution across Ultramarine & Pigments Limited’s diversified business segments including laundry products, IT-enabled services, and specialty pigments.

Operating margins remained healthy at 16.5%, while gross profit margins held steady at 30%. The company maintained strong liquidity with a current ratio of 2.48, indicating solid working capital management and financial stability.

Ultramarine & Pigments Limited Stock Valuation and Key Financial Metrics

ULTRAMAR.BO stock trades at a 14.73 P/E ratio, suggesting reasonable valuation relative to earnings power. The price-to-sales ratio of 1.60 indicates the market values the company fairly against revenue generation. Book value per share stands at $364.08, with the stock trading at 1.16x book value, reflecting modest premium to tangible assets.

Market capitalization reached $12.31 billion, with the company maintaining strong balance sheet metrics. Debt-to-equity ratio of 0.084 demonstrates conservative leverage, while interest coverage of 20.74x shows excellent ability to service obligations.

What to Watch in Ultramarine & Pigments Limited Earnings Report

Revenue growth of 24.4% year-over-year signals strong market demand across product lines. Net income expanded 30.3% compared to prior year, outpacing revenue growth and indicating operational leverage. The company’s IT-enabled services segment continues gaining traction, diversifying earnings beyond traditional chemicals.

Inventory management improved with days inventory outstanding at 74.5 days, while receivables collection remained efficient at 44 days. Free cash flow growth of 152% year-over-year demonstrates exceptional cash generation capability supporting future investments.

ULTRAMAR.BO Stock Forecast and Analyst Outlook

Meyka AI rates ULTRAMAR.BO with a grade of B+, suggesting solid fundamentals with room for improvement. Twelve-month price target forecasts reach $504.82, implying 24.6% upside from current levels. The company’s return on equity of 8.2% and return on capital employed of 10.9% indicate efficient capital deployment.

Technical indicators show neutral momentum with RSI at 54.33, suggesting balanced buying and selling pressure. The stock trades within Bollinger Bands, with support near $397.71 and resistance at $428.74, providing defined trading ranges for investors.

Final Thoughts

Ultramarine & Pigments Limited delivered strong Q2 2026 earnings with $1.96 billion revenue and $6.63 EPS, demonstrating solid operational performance across its specialty chemicals and services portfolio. Despite the positive results, ULTRAMAR.BO stock declined 3.15% post-announcement, reflecting broader market caution and profit-taking. With a B+ grade from Meyka AI and a 12-month price target of $504.82, the company offers reasonable value for investors seeking exposure to India’s specialty chemicals sector, though near-term volatility may persist.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Earnings estimates are analyst projections and not guarantees of actual results. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.